Literature DB >> 29637000

Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma.

Xinyuan Zhao1, Shuyu Sun1, Xiongqun Zeng1, Li Cui2.   

Abstract

Oral squamous cell carcinoma (OSCC) remains to be a challenging public health problem worldwide. However, the underlying molecular mechanism regulating the carcinogenesis of OSCC is poorly known. Gene expression profiles of GSE13601, GSE30784, GSE37991 and The Cancer Genome Atlas (TCGA) head and neck cancer were downloaded from gene expression omnibus (GEO) and TCGA database respectively. R software and bioconductor packages were used to compare and identify the differentially expressed genes (DEGs) between OSCC tissues and normal controls. The common DEGs were then subjected to gene ontology (GO) enrichment analysis, ingenuity pathway analysis (IPA), protein-protein interaction (PPI) network analysis as well as survival analysis. A total of 76 up- and 102 down-regulated DEGs were identified. Functional analysis revealed that these DEGs were associates with increased oncostatin M signaling, cell diapedesis and extravasation as well as reduced calcium signaling and loss of adherens junctions and tight junctions. A set of robust prognostic signatures including PLAU, CLDN8 and CDKN2A were identified from DEGs and could predict overall survival in OSCC patients from TCGA cohort. This three-gene signature was further successfully validated as a prognostic marker for overall survival prediction in another independent cohort GSE41613. In conclusion, our study has identified a registry of novel genes and pathways that play important roles in regulating the initiation and development of OSCC. A set of robust molecular signature is identified for prognostic prediction, which will provide useful guidance for therapeutic applications.

Entities:  

Keywords:  Gene ontology; ingenuity pathway analysis; oral squamous cell carcinoma; protein-protein interactions network; survival analysis

Year:  2018        PMID: 29637000      PMCID: PMC5883095     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  29 in total

Review 1.  Matrix metalloproteinases and collagen catabolism.

Authors:  Janelle L Lauer-Fields; Darius Juska; Gregg B Fields
Journal:  Biopolymers       Date:  2002       Impact factor: 2.505

Review 2.  Loss of tight junction barrier function and its role in cancer metastasis.

Authors:  Tracey A Martin; Wen G Jiang
Journal:  Biochim Biophys Acta       Date:  2008-11-14

3.  The Gene Expression Omnibus Database.

Authors:  Emily Clough; Tanya Barrett
Journal:  Methods Mol Biol       Date:  2016

4.  Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.

Authors:  Z S Zeng; A M Cohen; J G Guillem
Journal:  Carcinogenesis       Date:  1999-05       Impact factor: 4.944

5.  Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue cancer by immunohistochemistry.

Authors:  Zhuang Zhang; Jian Pan; Longjiang Li; Zhuomin Wang; Wenlin Xiao; Ningyi Li
Journal:  J Oral Pathol Med       Date:  2010-10-24       Impact factor: 4.253

6.  Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998.

Authors:  Clifton D Fuller; Samuel J Wang; Charles R Thomas; Henry T Hoffman; Randal S Weber; David I Rosenthal
Journal:  Cancer       Date:  2007-04-01       Impact factor: 6.860

7.  Claudin 8 Contributes to Malignant Proliferation in Human Osteosarcoma U2OS Cells.

Authors:  Jianqiang Xu; Yaoqi Yang; Ping Hao; Xiaoyi Ding
Journal:  Cancer Biother Radiopharm       Date:  2015-11       Impact factor: 3.099

8.  Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.

Authors:  Li Cui; Siliangyu Cheng; Xiaojun Liu; Diana Messadi; Yan Yang; Shen Hu
Journal:  Oncotarget       Date:  2016-12-13

Review 9.  Targeting calcium signaling in cancer therapy.

Authors:  Chaochu Cui; Robert Merritt; Liwu Fu; Zui Pan
Journal:  Acta Pharm Sin B       Date:  2016-12-13       Impact factor: 11.413

Review 10.  Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer.

Authors:  Ran Zhao; Bu Young Choi; Mee-Hyun Lee; Ann M Bode; Zigang Dong
Journal:  EBioMedicine       Date:  2016-05-03       Impact factor: 8.143

View more
  40 in total

1.  A three miRNAs signature for predicting the transformation of oral leukoplakia to oral squamous cell carcinoma.

Authors:  Huan Chen; Xiangzhen Liu; Zhenning Jin; Chenyu Gou; Minglu Liang; Li Cui; Xinyuan Zhao
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  Development and validation of a m6A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma.

Authors:  Xinyuan Zhao; Li Cui
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

3.  The Potential Diagnostic Value of Immune-Related Genes in Interstitial Fibrosis and Tubular Atrophy after Kidney Transplantation.

Authors:  Bin Yang; Dike Shi; Yahong Chen; Yi Zhu
Journal:  J Immunol Res       Date:  2022-06-17       Impact factor: 4.493

4.  Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples.

Authors:  Chu Chen; Pawadee Lohavanichbutr; Yuzheng Zhang; John R Houck; Melissa P Upton; Behnoush Abedi-Ardekani; Antonio Agudo; Wolfgang Ahrens; Laia Alemany; Devasena Anantharaman; David I Conway; Neal D Futran; Ivana Holcatova; Kathrin Günther; Bo T Hansen; Claire M Healy; Doha Itani; Kristina Kjaerheim; Marcus M Monroe; Peter J Thomson; Benjamin L Witt; Steven Nakoneshny; Lisa A Peterson; Stephen M Schwartz; Katie R Zarins; Mia Hashibe; Paul Brennan; Laura S Rozek; Gregory Wolf; Joseph C Dort; Pei Wang
Journal:  Oral Oncol       Date:  2019-12-10       Impact factor: 5.337

5.  Authentication of differential gene expression in oral squamous cell carcinoma using machine learning applications.

Authors:  Rian Pratama; Jae Joon Hwang; Ji Hye Lee; Giltae Song; Hae Ryoun Park
Journal:  BMC Oral Health       Date:  2021-05-29       Impact factor: 2.757

6.  A Combined Prediction Model for Lymph Node Metastasis Based on a Molecular Panel and Clinicopathological Factors in Oral Squamous Cell Carcinoma.

Authors:  Shu Wang; Tiancheng Li; Huan Liu; Wei Wei; Yang Yang; Chong Wang; Bo Li; Zhengxue Han; Zhien Feng
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

7.  Identification of SPRR3 as a novel diagnostic/prognostic biomarker for oral squamous cell carcinoma via RNA sequencing and bioinformatic analyses.

Authors:  Lu Yu; Zongcheng Yang; Yingjiao Liu; Fen Liu; Wenjing Shang; Wei Shao; Yue Wang; Man Xu; Ya-Nan Wang; Yue Fu; Xin Xu
Journal:  PeerJ       Date:  2020-06-17       Impact factor: 2.984

8.  PLAU Promotes Cell Proliferation and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.

Authors:  Guangjin Chen; Jiwei Sun; Mengru Xie; Shaoling Yu; Qingming Tang; Lili Chen
Journal:  Front Genet       Date:  2021-05-20       Impact factor: 4.599

9.  Genome-wide study of key genes and scoring system as potential noninvasive biomarkers for detection of suicide behavior in major depression disorder.

Authors:  Yue Zhao; Lei Wang; Yajuan Wu; Ziquan Lu; Shuyou Zhang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

10.  Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma.

Authors:  Xinyuan Zhao; Shanshan Si; Xiaona Li; Wenjuan Sun; Li Cui
Journal:  J Cancer       Date:  2020-05-18       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.